These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6731626)

  • 21. Common side effects associated with monoamine oxidase inhibitors.
    Remick RA; Froese C; Keller FD
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):497-504. PubMed ID: 2748873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abuse of monoamine oxidase inhibitors.
    Baumbacher G; Hansen MS
    Am J Drug Alcohol Abuse; 1992; 18(4):399-406. PubMed ID: 1449122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.
    Pope HG; Jonas JM; Hudson JI; Kafka MP
    Am J Psychiatry; 1985 Apr; 142(4):491-2. PubMed ID: 3976924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe daytime somnolence in patients treated with an MAOI.
    Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
    Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertensive episode associated with phenelzine and tap beer--a reanalysis of the role of pressor amines in beer.
    Tailor SA; Shulman KI; Walker SE; Moss J; Gardner D
    J Clin Psychopharmacol; 1994 Feb; 14(1):5-14. PubMed ID: 8151003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A remarkable response of chronic severe obsessive-compulsive neurosis to phenelzine.
    Mahgoub OM
    Acta Psychiatr Scand; 1987 Feb; 75(2):222-3. PubMed ID: 3565070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ; Masiar SJ
    Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seizures in a diabetic patient on monoamine oxidase inhibitors.
    Albareda M; Udina C; Escartín A; Corcoy R
    Am J Emerg Med; 1999 Jan; 17(1):107-8. PubMed ID: 9928719
    [No Abstract]   [Full Text] [Related]  

  • 33. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with premature medication discontinuation among responders to an MAOI or a tricyclic antidepressant.
    Agosti V; Stewart JW; Quitkin FM; Rabkin JG; McGrath PJ; Markowitz J
    J Clin Psychiatry; 1988 May; 49(5):196-8. PubMed ID: 3366755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mysterious MAOI hypertensive episodes.
    Kahn D
    J Clin Psychiatry; 1988 Jan; 49(1):38-9. PubMed ID: 3335491
    [No Abstract]   [Full Text] [Related]  

  • 38. Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam.
    Naylor MW; Grunhaus L; Cameron O
    J Nerv Ment Dis; 1987 Feb; 175(2):111-4. PubMed ID: 3806075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mania associated with high percentage of inhibition of monoamine oxidase.
    Bowden CL; Seleshi E; Javors MA
    Am J Psychiatry; 1989 Jan; 146(1):121. PubMed ID: 2912232
    [No Abstract]   [Full Text] [Related]  

  • 40. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
    Erfurth A; Schmauss M
    Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.